.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Predict branded drug patent expiration
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
Chubb
Medtronic
Fuji
Novartis
Johnson and Johnson
Merck
Fish and Richardson
Express Scripts
Cipla

Generated: July 20, 2017

DrugPatentWatch Database Preview

ORAGRAFIN SODIUM Drug Profile

« Back to Dashboard

Which patents cover Oragrafin Sodium, and what generic Oragrafin Sodium alternatives are available?

Oragrafin Sodium is a drug marketed by Bracco and is included in one NDA.

The generic ingredient in ORAGRAFIN SODIUM is ipodate sodium. There is one drug master file entry for this compound. Additional details are available on the ipodate sodium profile page.

Summary for Tradename: ORAGRAFIN SODIUM

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list36
Clinical Trials: see list2,352
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ORAGRAFIN SODIUM at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bracco
ORAGRAFIN SODIUM
ipodate sodium
CAPSULE;ORAL012967-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Express Scripts
Chubb
Dow
Moodys
Farmers Insurance
Colorcon
Covington
McKinsey
Mallinckrodt
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot